Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell therapy, raising the efficacy bar in many forms of the disease. But the ...
UK start-up Complement Therapeutics has raised an impressive €72 million ($79 million) in first-round financing that will be used to take a gene therapy for sight-robbing disease geographic atrophy ...
Complement component 3, often called C3, is an essential protein of the immune system. This protein plays a vital role in the body’s innate immune system, providing the first line of defense against ...
NORMAL guinea pig serum is the most common source of complement for the complement-fixation test, and may be used fresh or, more commonly, preserved either by freeze-drying or by Richardson's method 1 ...
In recent years, the complement system has been implicated in the pathophysiology and progression of many disorders, notably modulating inflammation and causing endothelial and organ damage 1. Acute ...
Abstract: Recent breakthroughs in reconfigurable intelligent surface (RIS) technology are reshaping next-generation wireless networks. In multi-RIS deployments, however, the received signal becomes a ...
The Opti-GAIN study from Complement Therapeutics is assessing the safety, tolerability, and preliminary efficacy in GA secondary to age-related macular degeneration (AMD) of CTx001. A first-in-human ...
Abstract: The existence of non-standard numbers in first-order arithmetics is a semantic obstacle for modelling our arithmetical skills. This article argues that so far there is no adequate approach ...
Macrophage phagocytosis is a major cytotoxic mechanism for therapeutic monoclonal antibodies (mAbs) that opsonize target cells. This antibody-dependent cellular phagocytosis (ADCP) can occur via the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results